-+ 0.00%
-+ 0.00%
-+ 0.00%

AprilBio Revises Largest Shareholder’s Borrowings to KRW 15.8 Billion After Partial Repayment

PUBT·10/23/2026 02:19:04
Listen to the news
AprilBio Revises Largest Shareholder’s Borrowings to KRW 15.8 Billion After Partial Repayment
  • AprilBio's Oct. 23, 2026, correction reduced its largest shareholder's borrowing to KRW 15.8 billion from KRW 48 billion following partial repayment.
  • The loan maturity was extended to Dec. 23, 2026, from Oct. 23, 2026.
  • Collateral remains KRW 57.6 billion, covering 1,663,779 shares; full enforcement would reduce IMM Healthcare No. 8's stake to 4.57% from 9.92%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AprilBio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261023900364), on October 23, 2026, and is solely responsible for the information contained therein.